A decision, likely to come in June, would be a major victory for the FDA’s authority to regulate prescription drugs and for abortion-rights advocates who have sought to protect access to mifepristone.
Related Posts
Guthrie has long wanted to overhaul Medicaid. Now he has to sell members on a compromise
The Energy and Commerce Committee chair is about to be put to the test.
RFK Jr. says US won’t donate to global vaccine effort
Kennedy ripped into Gavi, the Vaccine Alliance, in a video address at its pledging summit.
The anti-abortion wins buried in the Supreme Court’s unanimous ruling against them
Four ways the Supreme Court decision could serve the anti-abortion movement.